Chemotherapy of leishmaniasis : present challenges
ARTIGO
Inglês
Agradecimentos: We wish to thank Dr. Jeffrey J. Shaw for support and countless fruitful discussions. We thank Jenicer Yokoyama-Yasunaka for the continuous support. This work was supported by the São Paulo Research Foundation (FAPESP) (grant number 2015/09080-2) ; Conselh
Cutaneous and visceral leishmaniasis are amongst the most devastating infectious diseases of our time, affecting millions of people worldwide. The treatment of these serious diseases rely on a few chemotherapeutic agents, most of which are of parenteral u
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
473343/2012-6
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP
2015/09080-2; 2015/23832-7; 2012/14629-5
fechado
Chemotherapy of leishmaniasis : present challenges
Chemotherapy of leishmaniasis : present challenges
Fontes
Parasitology Vol. 145, no. 4 (Apr., 2018), p. 464-480 |